Announcements
Sidley Represents Valius Sciences in Financing Raising More Than US$10 Million for Future Cancer Diagnostics
April 23, 2026
Sidley represented Valius Sciences, a San Francisco-based healthcare diagnostics company focused on cancer treatment, in a Series Seed financing round that raised more than US$10 million. The round was led by 8VC and Basis Set Ventures.
More information about the transaction can be found here.
The Sidley team was led by Michael Podolny (Emerging Companies and Venture Capital) and included Daniel Wei (Emerging Companies and Venture Capital) and Laura DeMassa (M&A).
連絡先
得意分野
Suggested News & Insights
Sidley, Innovation Endeavors, and Premji Happy Hour Reception at JPMTuesday, January 12, 2027Recharge & Recaffeinate With Sidley @ JPMMonday, January 11, 2027 – Tuesday, January 12, 2027Sidley Represents RemeGen in Expanded US$356 Million Licensing Agreement With Vor BioNovember 16, 2026Sidley Represents Clearlake Capital Group in Mirendil’s US$1 Billion FinancingNovember 13, 2026Sidley Represents Laza Medical in Its US$160 Million Series B Financing RoundNovember 4, 2026Sidley Represents Hanmi Pharm and Green Cross Biopharma in Licensing Agreement With BioMarinOctober 30, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory

